Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Caliway Biopharmaceuticals CoTPE:6919 -4.82%55 Days Inventory is 312.34 as of Jun. 2026, which is 243% above its 10-year median of 90.94. GuruFocus rates TPE:6919 with a GF Score™ of 55/100 and a GF Value™ of NT$59.00 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 641 Biotechnology companies, Caliway Biopharmaceuticals Co ranks worse than 53.35% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Caliway Biopharmaceuticals Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.29.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caliway Biopharmaceuticals Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.19.
Caliway Biopharmaceuticals Co (TPE:6919) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Caliway Biopharmaceuticals Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Caliway Biopharmaceuticals Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Caliway Biopharmaceuticals Co Days Inventory Related Terms
Caliway Biopharmaceuticals Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caliway Biopharmaceuticals Co Days Inventory Chart
TPE:6919 vs VRTX, REGN, MRNA: Days Inventory Comparison
For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caliway Biopharmaceuticals Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Caliway Biopharmaceuticals Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caliway Biopharmaceuticals Co (TPE:6919) has a Days Inventory of 312.34 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caliway Biopharmaceuticals Co and its competitors. This is 243% above median its historical median of 90.94. Over the past decade, Caliway Biopharmaceuticals Co's Days Inventory has ranged from 0.93 to 198.51. According to the industry distribution chart, Caliway Biopharmaceuticals Co ranks #342 out of 641 companies in the Biotechnology industry, placing it in the top 53.4%.
Is Caliway Biopharmaceuticals Co's Days Inventory too high?
Caliway Biopharmaceuticals Co's current Days Inventory of 312.34 is 243% above median its 10-year median of 90.94. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 198.51. The Biotechnology industry median Days Inventory is 183.69. Caliway Biopharmaceuticals Co's value of 312.34 is 70% above this industry median. Based on the distribution chart, Caliway Biopharmaceuticals Co ranks #342 out of 641 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Caliway Biopharmaceuticals Co has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caliway Biopharmaceuticals Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Caliway Biopharmaceuticals Co ranks #342 out of 641 companies for Days Inventory. This places Caliway Biopharmaceuticals Co in the lower half of its industry. The industry median Days Inventory is 183.69. Caliway Biopharmaceuticals Co's value of 312.34 is 70% above this benchmark. Historically, Caliway Biopharmaceuticals Co's own Days Inventory has ranged from 0.93 to 198.51 over the past decade. While the company's 10-year median is 90.94 vs. the industry median of 183.69, Caliway Biopharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.69, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Caliway Biopharmaceuticals Co's current Days Inventory of 312.34 is 70% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Caliway Biopharmaceuticals Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caliway Biopharmaceuticals Co's current Days Inventory is 312.34, which is 243% above median its own 10-year median of 90.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliway Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Caliway Biopharmaceuticals Co (TPE:6919) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$59.00, compared to a current price of NT$94.80 — trading 60.7% above its estimated fair value. The current Days Inventory is 312.34, which is 243% above median its 10-year median of 90.94 and 70% above the Biotechnology industry median of 183.69. Caliway Biopharmaceuticals Co's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Caliway Biopharmaceuticals Co (TPE:6919), the current Days Inventory is 312.34 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Caliway Biopharmaceuticals Co (TPE:6919) Overvalued in 2026?
Based on GuruFocus' analysis, Caliway Biopharmaceuticals Co stock appears to be overvalued.
The current stock price of NT$94.80 is trading 60.7% above its estimated GF Value™ of NT$59.00.
GuruFocus considers Caliway Biopharmaceuticals Co to be Significantly Overvalued.
Key valuation signals for TPE:6919:
Days Inventory: 312.34 (243% above median its 10-year median of 90.94)
GF Value™: NT$59.00 vs. price of NT$94.80 (60.7% above fair value)
Industry Position: 70% above the Biotechnology median (#342 of 641)
No single metric tells the full story. See the TPE:6919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. The group has one operating segment, which is Healthy Food, and others.
55GF Score
Get the complete analysis for TPE:6919
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6919 has been successfully added to your 
